###begin article-title 0
Glypican-1 controls brain size through regulation of fibroblast growth factor signaling in early neurogenesis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Cell surface heparan sulfate proteoglycans (HSPGs) act as co-receptors for multiple families of growth factors that regulate animal cell proliferation, differentiation and patterning. Elimination of heparan sulfate during brain development is known to produce severe structural abnormalities. Here we investigate the developmental role played by one particular HSPG, glypican-1 (Gpc1), which is especially abundant on neuronal cell membranes, and is the major HSPG of the adult rodent brain.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 575 579 575 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 579 583 579 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice with a null mutation in Gpc1 were generated and found to be viable and fertile. The major phenotype associated with Gpc1 loss is a highly significant reduction in brain size, with only subtle effects on brain patterning (confined to the anterior cerebellum). The brain size difference emerges very early during neurogenesis (between embryonic days 8.5 and 9.5), and remains roughly constant throughout development and adulthood. By examining markers of different signaling pathways, and the differentiation behaviors of cells in the early embryonic brain, we infer that Gpc1-/- phenotypes most likely result from a transient reduction in fibroblast growth factor (FGF) signaling. Through the analysis of compound mutants, we provide strong evidence that Fgf17 is the FGF family member through which Gpc1 controls brain size.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 268 273 268 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 280 284 <span type="species:ncbi:10090">mice</span>
These data add to a growing literature that implicates the glypican family of HSPGs in organ size control. They also argue that, among heparan sulfate-dependent signaling molecules, FGFs are disproportionately sensitive to loss of HSPGs. Finally, because heterozygous Gpc1 mutant mice were found to have brain sizes half-way between homozygous and wild type, the data imply that endogenous HSPG levels quantitatively control growth factor signaling, a finding that is both novel and relevant to the general question of how the activities of co-receptors are exploited during development.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 376 377 376 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 600 601 600 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 531 535 <span type="species:ncbi:10090">mice</span>
Cell surface heparan sulfate proteoglycans (HSPGs) have been implicated as key regulators of patterning and growth in animal development [1,2]. Participation in these events is generally thought to reflect their functions as co-receptors for diverse growth factor families, including fibroblast growth factors (FGFs), Wnts, Hedgehogs and bone morphogenetic proteins (BMPs) [3-6]. In both vertebrates and invertebrates, disruption of heparan sulfate biosynthesis leads to severe, pervasive developmental abnormalities. For example, mice completely deficient in heparan sulfate arrest in gastrulation [7].
###end p 9
###begin p 10
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
In contrast, the elimination of the individual core proteins that carry cell surface heparan sulfate generally produces more subtle or tissue-restricted defects, particularly in mammals [8-16]. Most likely this reflects the relatively large number of cell surface HSPGs (six glypicans and four syndecans in mammals), their overlapping patterns of expression, and a likelihood of functional redundancy that is made particularly high by the fact that carbohydrate moieties mediate much of their function. Despite such complexity, the analysis of core protein mutants has provided novel insights into at least some of the developmental and physiological processes in which HSPGs participate.
###end p 10
###begin p 11
###xml 183 185 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 568 570 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 593 598 593 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 967 972 967 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 1188 1193 1188 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 944 948 <span type="species:ncbi:10090">mice</span>
###xml 1154 1158 <span type="species:ncbi:10090">mice</span>
The glypicans define a structurally conserved family of glycosylphosphatidylinositol-anchored HSPGs that have been extensively studied for their roles in both development and cancer [17-27]. Of the six glypicans in mammals, glypicans 1 and 2 (Gpc1 and Gpc2) were identified early on as major HSPGs of the developing brain [28-31]. Subsequently, Gpc4 and Gpc5 were shown to be regionally expressed in the developing brain as well [32-34]. Biochemical studies suggest that the most abundant glypican in the rodent brain, at least from late gestation onward, is Gpc1 [29,31]. During development, Gpc1 is expressed in both neuroepithelial cells and mature neurons; it is particularly enriched in axons and nerve terminals [35,36]. We reasoned, therefore, that loss of Gpc1 might produce defects in neurogenesis and/or axonal guidance, both of which are driven by growth factors regulated, in many cases, by HSPGs. As described below, the brains of mice rendered null for Gpc1 were morphologically normal, except for subtle mispatterning of the anterior cerebellum, but were abnormally small. Unexpectedly, we found that the reduction in brain size in mutant mice reflects a specific role for Gpc1 at the earliest stages of neurogenesis, before embryonic day (E)9.5.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 30 34 <span type="species:ncbi:10090">mice</span>
Generation of glypican-1 null mice
###end title 13
###begin p 14
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 528 530 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 573 577 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 577 585 573 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">tm1 Alan</sup>
###xml 615 619 611 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 619 620 615 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 665 670 661 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </italic>
###xml 726 730 722 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 730 734 726 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ</italic>
###xml 730 734 726 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LacZ</italic></sup>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 515 519 <span type="species:ncbi:10090">mice</span>
Homologous recombination was used in embryonic stem (ES) cells to flank the first exon of Gpc1 - which includes the translational start site and signal sequence - with loxP sites, and successfully targeted cells were transiently transfected with Cre recombinase to induce excision (Figure 1A). Several independently excised ES clones were injected into C57BL/6 blastocysts to generate chimeric mice, one of which was extensively outcrossed to outbred (CD1; >/=10 generations) and inbred (C57Bl/6; >/=7 generations) mice (Figure 1B). This mutant allele (formally designated Gpc1tm1 Alan) will be referred to here as Gpc1-. A second allele - a gene trap insertion of LacZ into the fourth intron of Gpc1 - will be referred to as Gpc1LacZ.
###end p 14
###begin p 15
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Targeted mutation of the Gpc1 locus creates a null allele</bold>
###xml 59 63 59 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 203 205 203 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TK</italic>
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo</italic>
###xml 511 516 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 575 579 575 579 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 601 606 601 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 658 662 658 662 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 1168 1172 1168 1172 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 1478 1484 1478 1484 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E-G) </bold>
###xml 1496 1504 1496 1504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1522 1527 1522 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 1676 1681 1676 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 1786 1793 1786 1793 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(H, I) </bold>
###xml 1805 1813 1805 1813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1831 1836 1831 1836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 1857 1861 1857 1861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1861 1865 1861 1865 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1999 2004 1999 2004 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
Targeted mutation of the Gpc1 locus creates a null allele. (A) Targeting strategy. A construct was created in which loxP sites flank exon 1 of Gpc1 and FLP recognition target (FRT) sites flank negative (TK) and positive (neo) selection markers. After transfection into embryonic stem (ES) cells, Southern blotting, using a probe located outside the targeted region, permitted verification of targeted integration. Transient tranfection of targeted ES cells with a Cre expression plasmid was then used to remove Gpc1 exon 1 and selection markers, prior to generation of mice. (B) Identification of the Gpc1 wild-type (+) and mutant (-) allele by PCR in mice. (C) Immunoblotting of adult brain membrane fractions with an anti-Gpc1 antibody. The presence of a discrete band found only in samples pretreated with heparitinase (Hase) demonstrates that the immunoreactive molecule is a heparan sulfate proteoglycan (HSPG) core protein. Note the decreased band intensity in heterozygous animals, and complete absence of immunoreactivity in homozygotes. The small apparent difference in mobility and slight tilt of the wild-type band is an artifact of uneven electrophoresis. (D) Immunoblotting of adult brain membrane HSPG core proteins using 3G10 antibody. Notice that the loss of a band at the correct molecular weight for Gpc1 in mutant animals is not accompanied by a substantial, consistent change in the presence of other HSPG cores. Hase, Heparitinase; Case, Condroitinase ABC. (E-G) Whole-mount in situ hybridization for Gpc1 at E8.5. Genotypes are as indicated. Red arrowheads point to areas of high Gpc1 expression in the developing brain and branchial arches. Notice that Gpc1 expression is greatly reduced or absent in homozygous mutants. Levels in heterozygotes are intermediate. (H, I) Whole-mount in situ hybridization for Gpc1 in wild-type (H) and Gpc1-/- (I) embryos at E9.5. Staining has been deliberately overdeveloped to show the absence of signal in the mutant, suggesting that mutant Gpc1 mRNA is unstable. FB, forebrain; HB, hindbrain; MB, midbrain.
###end p 15
###begin p 16
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ</italic>
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </italic>
###xml 16 26 16 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LacZ</italic>/<italic>LacZ </italic></sup>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 222 226 222 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 285 289 285 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C,D</xref>
###xml 415 417 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 491 495 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 495 499 495 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 507 511 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ</italic>
###xml 512 517 512 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </italic>
###xml 507 517 507 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LacZ</italic>/<italic>LacZ </italic></sup>
###xml 535 543 535 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 641 646 641 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 661 665 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 665 669 665 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 685 689 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E-I</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 517 521 <span type="species:ncbi:10090">mice</span>
Gpc1-/- and Gpc1LacZ/LacZ mice were viable and fertile on outbred and inbred backgrounds, and appeared grossly normal. Biochemical studies revealed a complete absence of Gpc1 core protein from the brains of homozygous Gpc1-/- animals, with intermediate levels in heterozygotes (Figure 1C,D). The expression of other brain heparan sulfate and chondroitin sulfate proteoglycans was not significantly affected (Figure 1D). Immunohistochemistry also demonstrated a loss of Gpc1 staining in both Gpc1-/- and Gpc1LacZ/LacZ mice (not shown). In situ hybridization studies, using both whole embryos and adult brain sections, also revealed a lack of Gpc1 transcripts in Gpc1-/- animals (Figure 1E-I), suggesting that these animals are essentially protein- and message-null.
###end p 16
###begin title 17
Loss of glypican-1 leads to reduced brain size and subtle patterning abnormalities of the cerebellum
###end title 17
###begin p 18
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 282 286 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 286 290 286 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 344 348 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 348 352 346 350 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/+ </sup>
###xml 393 395 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 540 542 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 502 507 <span type="species:ncbi:10090">mouse</span>
Gpc1-/- mice were indistinguishable from wild type in gross appearance, size, lifespan, and a variety of simple behaviors (data not shown). Their internal anatomy appeared normal, with the exception of the brain, which was noticeably small (Figure 2A). On the CD1 background, adult Gpc1-/- brains weighed 15.5 +/- 1.0% less than wild type, and Gpc1-/+ brains weighed 7.8 +/- 1.0% less (Figure 2B). Both results were highly statistically significant, as variation in brain size among individuals within mouse strains is normally very small [37].
###end p 18
###begin p 19
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Adult brain weight from Gpc1 null mutant is significantly reduced</bold>
###xml 67 71 67 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 162 166 162 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 174 181 174 181 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B, C) </bold>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 305 310 305 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 319 321 319 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 401 403 401 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 499 503 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 503 508 503 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </italic>
###xml 503 508 503 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LacZ </italic></sup>
###xml 543 547 543 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ</italic>
###xml 557 561 557 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ</italic>
###xml 562 566 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ</italic>
###xml 568 572 568 572 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 594 599 594 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 736 740 736 740 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E) </bold>
###xml 869 873 869 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 873 877 873 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 887 889 887 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Adult brain weight from Gpc1 null mutant is significantly reduced. (A) Dorsal views of freshly dissected adult brains. Note the apparent reduction in size of Gpc1-/- brains. (B, C) Wet weights of fresh adult brains. Gpc1 genotypes are as indicated. There is a 15.5% decrease in brain weight in homozygous Gpc1 mutants (P < 0.0001); heterozygotes show an intermediate phenotype (7.8% decrease; * and **P < 0.0001). (B) N = 32 for +/+; 29 for +/-; 36 for -/-. Reduced brain weight is also observed in Gpc1LacZ mutants. (C) N = 9 for +/+; 10 for LacZ/+; 7 for LacZ/LacZ. (D) Body weights of adult Gpc1 mutant and wild-type littermates, grouped by sex. No significant effect of genotype is observed. N = 23 for +/+; 30 for +/-; 37 for -/-. (E) Total DNA content of mutant and wild-type brains was measured as an indication of cell number. The data imply a 20% reduction in Gpc1-/- brains. (*P < 0.001; N = 5 for +/+, and 5 for -/-).
###end p 19
###begin p 20
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 43 47 43 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 55 59 55 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/+ </sup>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 124 127 124 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ</italic>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </italic>
###xml 302 312 302 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LacZ</italic>/<italic>LacZ </italic></sup>
###xml 526 528 526 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 535 540 535 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </sup>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
On a C57/Bl6 background, reductions in Gpc1-/- and Gpc1-/+ brain weight were also evident, but less pronounced (11% for Gpc1-/-; data not shown), possibly reflecting the fact that wild-type C57/Bl6 brains are approximately 5% smaller than wild-type CD1 brains to begin with. As shown in Figure 2C, Gpc1LacZ/LacZ mice also displayed reduced brain size (the higher variance of these data likely reflects the mixed CD1/C57 background of these animals). The brain weight reduction did not correlate with sex or body weight in Gpc1- or Gpc1LacZ mutant animals (Figure 2D).
###end p 20
###begin p 21
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 210 212 210 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2E</xref>
###xml 214 218 214 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 218 222 218 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 308 313 308 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 222 226 <span type="species:ncbi:10090">mice</span>
To determine whether changes in brain size were due to the presence of fewer cells or smaller cells, DNA was extracted from whole brains and quantified using Hoechst 33258 fluorescence [38]. As shown in Figure 2E, Gpc1-/- mice had about 20% less DNA per brain than their wild-type littermates. Thus, loss of Gpc1 leads to a 20% decrease in the number of brain cells.
###end p 21
###begin p 22
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 32 36 32 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 93 94 93 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 309 313 309 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A-F</xref>
###xml 573 578 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ext1 </italic>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 679 684 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 700 704 700 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3G-J</xref>
###xml 814 818 814 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3K-N</xref>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
Despite this, the shapes of Gpc1-/- forebrains were morphometrically normal (Additional file 1), and most structures showed no apparent patterning defects. The major exception was found in the gyri of the cerebellar vermis, where the most anterior lobe (lobe I) either did not form or was rudimentary (Figure 3A-F). In addition, the primary fissure was shortened by 12%, with no significant change in the lengths of the other fissures, or in the overall cerebellar perimeter (data not shown). Notably, structures that are disrupted in heparan sulfate-deficient conditional Ext1 mutant mice, such as the interhemispheric commissures and the forebrain septum [39], were present in Gpc1 mutants (Figure 3G-J). In addition, no obvious changes in lamination of the cerebellar or cerebral cortices were observed (Figure 3K-N; and data not shown), and staining for markers of neuronal subpopulations, such as calbindin and parvalbumin, appeared normal (data not shown).
###end p 22
###begin p 23
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cerebellar foliation defects in Gpc1 null mice</bold>
###xml 48 54 48 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-F) </bold>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 298 302 298 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 308 314 308 314 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G-J) </bold>
###xml 461 465 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 465 469 465 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 475 481 475 481 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(K-N) </bold>
###xml 645 649 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 649 653 649 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
Cerebellar foliation defects in Gpc1 null mice. (A-F) Development of cerebellar foliation. Nissl-stained mid-sagittal sections are shown at postnatal days (P)0, 7 and 27. Lobes I to X are as marked in (H). As early as P7, a loss or severe reduction in folium one (red arrowhead) can be seen in Gpc1-/- mice. (G-J) Forebrain anatomy. Coronal sections at the level of the hippocampus (G, H) and septum (I, J) show that midline commissural tracts appear normal in Gpc1-/- mice. (K-N) Cerebellar lamination. Horizontal sections at P7 (K, L) and P27 (M, N) are shown. The appearance and thickness of the cellular and fiber tract layers are normal in Gpc1-/- mice. CC, corpus callosum; EGL, external granular layer; HC, hipocampal commissure; IGL, internal granular layer; ML, molecular layer; PL, purkinje cell layer; S, septum. Bars in (F, H, J) = 1 mm.
###end p 23
###begin title 24
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
Brain size reduction reflects an early embryonic requirement for Gpc1
###end title 24
###begin p 25
###xml 73 75 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 271 275 271 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 327 331 327 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 702 703 702 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A-B</xref>
###xml 754 758 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 758 762 758 762 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 838 840 838 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
Although Gpc1 has been reported to be the major HSPG of the adult brain [35], it is also expressed throughout development of the nervous system, and can be detected in neural tissue as early as head-fold stage (around E7) [35,40]. We therefore measured brain size in Gpc1-/- mice at various developmental stages. At birth, Gpc1-/- brains weighed 15 to 20% less than wild-type brains, that is, they were smaller to about the same degree as seen in adulthood (data not shown). Prior to birth, weights could not be measured accurately given the small size of embryonic brains and the need to dissect under liquid; instead, volumes were estimated from photographic images of fresh embryos (Additional file 2). As shown in Figure 4A-B the estimated volume of Gpc1-/- brains was 22% below that of wild-type littermates as early as E9.5 (Figure 4B). In contrast, brain volumes measured one day earlier (E8.5) exhibited no difference between mutant and wild-type littermate embryos. Apparently, a phenotype of about the same magnitude as seen in adult animals emerges over the course of a single day of development.
###end p 25
###begin p 26
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 0 67 0 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The <italic>Gpc1 </italic>mutant brain phenotype emerges early in neural development</bold>
###xml 69 73 69 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 148 152 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 152 156 152 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 366 370 366 370 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 374 378 374 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 510 511 510 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 820 822 820 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 827 828 827 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 840 842 840 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 847 848 847 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 939 941 939 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1031 1035 1031 1035 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 1118 1122 1118 1122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1122 1126 1122 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1239 1243 1239 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1243 1247 1243 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1312 1318 1312 1318 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D-F) </bold>
###xml 1648 1655 1648 1655 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G, H) </bold>
###xml 1735 1739 1735 1739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1739 1743 1739 1743 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2092 2094 2092 2094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The Gpc1 mutant brain phenotype emerges early in neural development. (A) Lateral images of embryonic day (E)8.5, E9.5 and E11.5 wild-type (+/+) and Gpc1-/- (-/-) embryos. Because the developmental stage of embryos is highly variable at E8.5 to E9.5, not every image is fully representative of the average for that genotype (for quantitative data, see (B, C) below). (B) Gpc1-/- embryos display smaller brains starting at E9.5. Brain size was estimated from photographic images, as described in Additional file 2. Averages of estimated cranial area (at E8.5 and E9.5) and cranial volume (E11.5) were obtained for wild-type and homozygous mutant embryos in multiple litters (N = 23 for +/+ and N = 15 for -/- at E8.5; N = 25 for +/+ and N = 22 for -/- at E9.5; N = 10 for +/+ and N = 18 for -/- at E11.5). Units are pixels2 (x 104) and pixels3 (x 106) for area and volume measurements, respectively. Note the 14.1% decrease in area (* and **P < 0.05) that emerges at E9.5 (consistent with an approximately 20.4% decrease in volume). (C) Comparison of cranial area with somite number in E8.5 and E9.5 wild-type (+/+) and Gpc1-/- (-/-) embryos. Linear regression lines demonstrate that, even when variation in somite number is controlled for, Gpc1-/- brains are of normal size at E8.5, and abnormally small at E9.5. (D-F) Quantification of cell proliferation in the embryonic brain. Sagittal sections of E9.5 embryos were immunostained for phosphohistone H3 (PHH3) (D), counterstained with bizbenzamide (E) and the two images merged (F). Note the concentration of labeled cells along the pial and ventricular margins of the neuroepithelium (outlined). (G, H) Sets of serial sections were stained in this manner from multiple wild-type and Gpc1-/- embryos at E8.5 (N = 5 for both +/+ and -/-), E9.5 (N = 8 for +/+ and N = 7 for -/-), and E11.5 (N = 7 for +/+ and N = 6 for -/-), and numbers of PHH3-labeled cells within the neuroepithelium were counted and normalized to neuroepithelial area for either the entire embryo (G) or the forebrain alone (H). The data show a statistically significant (*P < 0.001) decrease in PHH3-labeling index at E9.5, but no change at E11.5.
###end p 26
###begin p 27
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 283 287 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 287 291 287 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 706 711 698 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
To test whether the smaller brain size of E9.5 mutant embryos is a consequence of general developmental delay, we plotted brain size against somite number, a marker of developmental stage (Figure 4C). The data showed a slight trend - which was not statistically significant - toward Gpc1-/- embryos being delayed by about 1 somite (at E8.5, wild type = 11.5 +/- 2.8 and mutant = 10.3 +/- 3.2; at E9.5, wild type = 22.0 +/- 2.4 and mutant = 21.2 +/- 2.4). Even taking such a trend into account, regression analysis showed that >70% of the brain size difference at E9.5 is independent of somite number (note the downward shift of the regression line at E9.5). These data suggest that, between E8.5 and E9.5, Gpc1 plays a specific and important role in nervous system growth.
###end p 27
###begin p 28
###xml 169 173 169 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D-H</xref>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 562 566 562 566 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
To test whether that role involves regulation of cell proliferation, we used phospho-histone H3 immunohistochemistry to quantify the density of cells in M-phase (Figure 4D-H). If one considers the early central nervous system as a mass of cycling cells undergoing exponential expansion, with a typical cell cycle time of about 8 hours [41,42], then in order to produce a 20% reduction in cell mass over the course of one day of development (and no further decrease thereafter), one would need to lengthen the cell cycle during that day by about 7%. Thus, in Gpc1-/- embryos, we initially expected to see up to an approximately 7% decrease in mitotic labeling index at E8.5, followed by a return to normal on the following day.
###end p 28
###begin p 29
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G</xref>
###xml 256 258 256 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4H</xref>
###xml 495 499 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 499 503 499 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Interestingly, we observed a larger and longer-lasting change in labeling index. For example, at E9.5, when we expected proliferation to have returned to wild-type levels, the labeling index in mutant brain neuroepithelium was decreased by 30% (Figure 4G; P < 0.001) The effect was specific to the neuroepithelial cells of these embryos (Additional file 3), and did eventually disappear (by E11.5; Figure 4H). We considered the possibility that the larger-than expected drop in proliferation in Gpc1-/- embryos was being offset by decreased cell death, but this was not supported by direct measurements. TUNEL staining showed that dying cells are not particularly abundant in the wild-type central nervous system at these stages, and if anything, displayed a trend (not statistically significant) toward being more abundant in the mutant, not less. A likely explanation for the delayed and larger-than-expected drop in neural labeling index became apparent later on, after more information about the probable mechanism of GPC1 action was obtained (see below).
###end p 29
###begin title 30
Redundancy versus compensation within the glypican family
###end title 30
###begin p 31
###xml 132 136 132 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 136 140 136 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 262 266 262 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2</italic>
###xml 268 271 268 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc</italic>
###xml 274 278 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 280 283 280 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc</italic>
###xml 290 293 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc</italic>
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc3 </italic>
###xml 415 420 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc5 </italic>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A-E</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 586 594 586 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 640 644 640 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 644 648 644 648 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A-J</xref>
###xml 778 782 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 794 799 794 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4 </italic>
###xml 867 871 867 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 871 875 871 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 875 879 <span type="species:ncbi:10090">mice</span>
Six structurally similar glypicans are encoded by the mammalian genome. A possible explanation for the relatively mild phenotype in Gpc1-/- mutants would be the participation of other glypicans in the regulation of early embryonic neural proliferation. In fact, Gpc2, Gpc3, Gpc4, Gpc5, and Gpc6 can all be detected in E8.5 and E9.5 embryos, although Gpc3 expression is excluded from most of the nervous system, and Gpc5 is not strongly expressed in brain until later stages (Figure 5A-E) [30,36,40,43]. Interestingly, the expression levels of Glypicans 2 to 6, as judged by whole mount in situ hybridization, were not noticeably altered in Gpc1-/- mutants (Figure 5A-J), suggesting that there is little or no compensatory up-regulation of other glypicans in response to loss of Gpc1. Levels of Gpc4 RNA were also measured by quantitative RT-PCR and were unchanged in Gpc1-/- mice (data not shown).
###end p 31
###begin p 32
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Influences of other glypicans on brain size regulation</bold>
###xml 56 62 56 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-J) </bold>
###xml 74 82 74 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2</italic>
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc3</italic>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc5 </italic>
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc6 </italic>
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 164 168 164 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 284 291 284 291 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(K, L) </bold>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 358 360 358 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2</italic>
###xml 369 371 369 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 379 383 379 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 383 385 383 385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 394 399 394 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </sup>
###xml 458 462 458 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 462 467 462 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </sup>
###xml 578 582 578 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 582 589 582 589 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LacZ/+ </sup>
###xml 594 598 594 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 598 608 598 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LacZ/LacZ </sup>
###xml 632 637 632 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4 </italic>
###xml 820 824 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2</italic>
###xml 824 828 824 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 908 913 908 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2 </italic>
###xml 942 946 942 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 946 950 946 950 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 974 978 974 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 978 983 978 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </sup>
###xml 1019 1023 1019 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1023 1027 1023 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1046 1048 1046 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1068 1072 1068 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1072 1075 1072 1075 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1076 1080 1076 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2</italic>
###xml 1080 1083 1080 1083 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1095 1099 1095 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1099 1102 1099 1102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1103 1107 1103 1107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2</italic>
###xml 1107 1110 1107 1110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1122 1126 1122 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1126 1129 1126 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1130 1134 1130 1134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2</italic>
###xml 1134 1137 1134 1137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1149 1153 1149 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1153 1156 1153 1156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1157 1161 1157 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2</italic>
###xml 1161 1164 1161 1164 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1176 1180 1176 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1180 1183 1180 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1184 1188 1184 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 1188 1192 1188 1192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1210 1213 1210 1213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1220 1221 1220 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y</italic>
###xml 1218 1221 1218 1221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/<italic>Y</italic></sup>
###xml 1233 1237 1233 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1237 1240 1237 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1241 1245 1241 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 1245 1249 1245 1249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1267 1270 1267 1270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1277 1278 1277 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Y</italic>
###xml 1275 1278 1275 1278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/<italic>Y</italic></sup>
###xml 1291 1295 1291 1295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1295 1298 1295 1298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 1299 1303 1299 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 1303 1309 1303 1309 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Lacz/Y</sup>
###xml 1321 1325 1321 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1325 1328 1325 1328 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1329 1333 1329 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 1333 1339 1333 1339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LacZ/Y</sup>
###xml 174 179 <span type="species:ncbi:10090">mouse</span>
###xml 950 955 <span type="species:ncbi:10090">mouse</span>
Influences of other glypicans on brain size regulation. (A-J) Whole-mount in situ hybridization for Gpc2, Gpc3, Gpc4, Gpc5 and Gpc6 in E9.5 wild-type (A-E) and Gpc1-/- (F-J) mouse embryos suggests that there is no significant upregulation of other glypicans in response to Gpc1 loss. (K, L) Wet weights of fresh adult brains from allelic combinations of Gpc1- with Gpc2- (K) and Gpc1- with Gpc4lacZ (L). Genotypes are as indicated. The insertion site of the Gpc4LacZ gene-trap allele has not been mapped, precluding development of an allele-specific PCR reaction to distinguish Gpc4LacZ/+ from Gpc4LacZ/LacZ animals. However, since Gpc4 is located on the X chromosome, males with a single LacZ allele are unambiguously hemizygous. Thus, the comparison in (L) is between wild-type (both sexes) and LacZ+ males. Note that Gpc2-/- brains are not significantly different in size from wild type, nor does loss of Gpc2 enhance the phenotype of the Gpc1-/- mouse. In contrast, the Gpc4LacZ mutation significantly enhances the Gpc1-/- phenotype (* and **P < 0.005). N = 7 for Gpc1+/+;Gpc2+/+, N = 5 for Gpc1+/+;Gpc2-/-, N = 3 for Gpc1-/-;Gpc2+/+, N = 3 for Gpc1-/-;Gpc2-/-, N = 2 for Gpc1+/+;Gpc4+/+ and N = 4 for Gpc1+/+;Gpc4+/Y, N = 3 for Gpc1-/-;Gpc4+/+ and N = 8 for Gpc1-/-;Gpc4+/Y, N = 14 for Gpc1+/+;Gpc4Lacz/Y, N = 9 for Gpc1-/-;Gpc4LacZ/Y.
###end p 32
###begin p 33
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2 </italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4 </italic>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc6</italic>
###xml 275 280 275 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2 </italic>
###xml 389 394 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2 </italic>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5K</xref>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2</italic>
###xml 483 487 483 487 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 535 539 535 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 539 543 539 543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 544 548 544 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2</italic>
###xml 548 552 548 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 596 600 596 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 600 604 600 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 360 364 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
To test for redundancy between Gpc1 and the other glypicans that are expressed in early embryonic brain, we generated double mutants with Gpc2 and Gpc4 (mutants in Gpc6, the third glypican that is strongly expressed in early embryonic brain, have not yet been produced). For Gpc2 we used a targeted allele that, when homozygous, produces phenotypically normal mice with a complete loss of Gpc2 protein (S Saunders and ADL, unpublished data). As shown in Figure 5K, the brains of Gpc2-/- mice are not reduced in size, and the brains of Gpc1-/- ;Gpc2-/- double mutants are no smaller than those of Gpc1-/- mice.
###end p 33
###begin p 34
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4 </italic>
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 94 98 94 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ</italic>
###xml 94 98 94 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LacZ</italic></sup>
###xml 153 155 153 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5L</xref>
###xml 228 232 228 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 232 237 232 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </italic>
###xml 232 237 232 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>LacZ </italic></sup>
###xml 368 373 368 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4 </italic>
In contrast, when compound mutants were made between Gpc1 and a gene-trap allele of Gpc4 (Gpc4LacZ), brain size appeared synergistically reduced (Figure 5L). This experiment may underestimate the contribution of Gpc4, since the Gpc4LacZ allele is very likely not null (unpublished observations). Thus, within the limits of what can be assessed using existing mutants, Gpc1 appears to act redundantly with at least Gpc4 in controlling brain size.
###end p 34
###begin title 35
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
Evidence for impairment of FGF signaling in the early Gpc1 mutant embryo
###end title 35
###begin p 36
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 347 351 347 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 370 378 370 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 351 355 <span type="species:ncbi:10090">mice</span>
Numerous growth factor and morphogen signaling pathways have been implicated in the control of brain growth and development [44-47]. Many of these pathways - including those mediated by Hedgehogs, Wnts, BMPs, and FGFs - are influenced by HSPGs in at least some developmental contexts [1,5,48,49]. To screen for disruption of these pathways in Gpc1-/- mice, we performed in situ hybridization at E8.5 and E9.5 for known downstream markers or reporter genes.
###end p 36
###begin p 37
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 363 369 363 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pyst1 </italic>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mkp3 </italic>
###xml 393 398 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dusp6</italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 447 451 447 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A-D</xref>
###xml 498 508 498 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sprouty 2 </italic>
###xml 509 514 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry2</italic>
###xml 597 611 597 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry2 in situ </italic>
###xml 652 656 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 656 660 656 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 691 695 691 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E-H</xref>
###xml 761 762 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 841 843 841 843 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6I</xref>
###xml 874 880 874 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry2 </italic>
###xml 888 892 888 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 892 896 892 896 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 935 941 935 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry1 </italic>
###xml 1029 1037 1029 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1052 1058 1052 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pyst1 </italic>
###xml 451 456 <span type="species:ncbi:10090">mouse</span>
Although we saw no significant differences between wild-type and mutant embryos at these stages in the expression patterns of marker genes for Sonic hedgehog (Shh), BMP and Wnt signaling (Additional file 4), the data suggested that FGF signaling was potentially attenuated. For one marker of FGF signaling - the mitogen-activated protein (MAP) kinase phosphatase Pyst1 (also known as Mkp3 and Dusp6) - we observed no significant change in the Gpc1-/- mouse (Figure 6A-D), but for a second marker - Sprouty 2 (Spry2) - we noticed a consistent, yet transient, reduction in expression. Specifically, Spry2 in situ hybridization was consistently weaker in Gpc1-/- brains at E8.5 to E9.5 (Figure 6E-H), but returned to a near-normal level by E10.25 (Additional file 5). To verify this result, we turned to quantitative RT-PCR. As shown in Figure 6I, there was a 40% reduction in Spry2 mRNA in Gpc1-/- brains at E9.5, with some reduction in Spry1 mRNA (also a FGF target gene) as well. In contrast, and in agreement with the data from in situ hybridization, Pyst1 levels were unchanged.
###end p 37
###begin p 38
###xml 0 121 0 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Loss of Gpc1 results in weakened fibroblast growth factor (FGF) signaling and premature neuronal differentiation in brain</bold>
###xml 123 129 123 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-D) </bold>
###xml 129 137 129 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pyst1</italic>
###xml 162 168 162 168 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E-H) </bold>
###xml 168 176 168 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 194 204 194 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sprouty 2 </italic>
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry2</italic>
###xml 260 266 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry2 </italic>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 358 362 358 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 409 413 409 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(I) </bold>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pyst1</italic>
###xml 453 459 453 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry1 </italic>
###xml 489 495 489 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry2 </italic>
###xml 537 541 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 541 545 541 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 607 613 607 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry2 </italic>
###xml 635 640 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 649 651 649 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 688 693 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry1</italic>
###xml 695 699 695 699 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(J) </bold>
###xml 738 747 738 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 806 810 806 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 814 818 814 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 818 822 818 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1040 1042 1040 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1069 1070 1069 1070 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 1073 1080 1073 1080 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(K, L) </bold>
###xml 1106 1110 1106 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1110 1114 1110 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 1122 1126 1122 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1126 1130 1126 1130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1276 1285 1276 1285 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(K', L') </bold>
###xml 1628 1632 1628 1632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1639 1646 1639 1646 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(M, N) </bold>
###xml 1850 1854 1850 1854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 1854 1858 1854 1858 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2011 2013 2011 2013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Loss of Gpc1 results in weakened fibroblast growth factor (FGF) signaling and premature neuronal differentiation in brain. (A-D) In situ hybridization for Pyst1. (E-H) In situ hybridization for Sprouty 2 (Spry2). Both are markers of FGF signaling and only for Spry2 was a noticeable change observed between genotypes, with apparent reduced expression in Gpc1-/- embryos at both embryonic day (E)8.5 and E9.5. (I) Real-time quantitative RT-PCR of Pyst1, Spry1 (a third FGF-target gene) and Spry2 from RNA isolated from E9.5 wild-type and Gpc1-/- forebrains. The data imply a significant reduction (32.5%) in Spry2 message levels in the Gpc1 mutant (*P < 0.01), and a possible reduction in Spry1. (J) Erk enzymatic activity was measured by in vitro phosphorylation in E9.5 dorsal forebrain explants from Gpc1+/+ and Gpc1-/- embryos. Such explants display a high level of basal (unstimulated) Erk activity, presumably due to the actions of endogenous growth factors. Erk activity was found to be 41% lower in mutant tissue than in wild type (*P < 0.005; units are cpm x 104). (K, L) Sagittal sections of E9.5 Gpc1+/+ (K) and Gpc1-/- (L) embryos were immunostained with Tuj1 (red), a marker for postmitotic neurons, and counterstained with the nuclear marker bizbenzamide (blue). (K', L') Enlarged images from white boxes in (K) and (L), corresponding to similar locations in the anterior midbrain. Note the greater density of Tuj1-positive cells in the mutant midbrain. White arrowheads in (K, L) point to the ventral forebrain, where virtually no Tuj1-positive cells are found in the wild-type, but several are present in the Gpc1-/- brain. (M, N) Numbers of Tuj1-positive cells within the forebrain (FB) and midbrain (MB) were totaled over serial sections of whole embryos at E8.5 (M) and E9.5 (N). Note the >2-fold increase in Tuj1-positive cells in Gpc1-/- brains at E9.5. In contrast, no significant difference is observed at E8.5. At E9.5, N = 7 for +/+ and N = 4 for -/-; at E8.5, N = 4 for each genotype. *P < 0.005.
###end p 38
###begin p 39
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 125 129 125 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6J</xref>
###xml 410 414 410 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 414 418 414 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 722 726 722 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 726 730 726 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 915 920 915 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
To examine FGF signaling more directly, we produced short-term E9.5 dorsal forebrain explant cultures from wild-type and Gpc1-/- embryos, and measured the enzymatic activity of extracellular regulated kinase (ERK) MAP kinase. As shown in Figure 6J, wild-type explants exhibited a high basal level of ERK activity, suggesting a high degree of endogenous growth factor signaling within the explant. In contrast, Gpc1-/- explants exhibited 41% less ERK activity under the same conditions. In response to exogenous FGF2, wild-type explants displayed only a small additional increase in ERK activity, possibly because endogenous signaling was so high. We consistently observed that the exogenous FGF response was even lower in Gpc1-/- explants, but due to the small size of the FGF effect we were unable to establish statistical significance for this conclusion (data not shown). Overall, the data strongly suggest that Gpc1 deficiency diminishes the response of cells of the early nervous system to FGFs.
###end p 39
###begin title 40
Loss of glypican-1 results in premature differentiation of postmitotic neurons
###end title 40
###begin p 41
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 510 512 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 643 645 643 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
It is widely reported that FGFs promote the proliferation of neural progenitor cells [50-59]. In most cases, FGFs appear not to act by affecting cell cycle kinetics, but by increasing the probability that the progeny of dividing cells remain in the cell cycle instead of differentiating (that is, FGFs suppress cell cycle exit). Such a mechanism of FGF action has been established, for example, in the cerebral cortex, the midbrain, the olfactory epithelium and the telencephalic subventricular zone [50,52,53,55,58]. Indeed, even in non-neural tissues such as muscle, preventing cell cycle exit seems to be the central mode of action of FGF [60,61].
###end p 41
###begin p 42
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 118 122 118 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6K-N</xref>
###xml 389 393 389 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 393 397 393 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 541 546 541 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 579 581 579 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 942 943 940 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 956 960 954 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 960 964 958 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1017 1019 1013 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
If impairment of FGF signaling is the primary mechanism by which Gpc1 deficiency reduces brain size, we reasoned that Gpc1-deficient embryos should exhibit accelerated cell cycle exit and, as a consequence, premature neuronal differentiation. Indeed, this turned out to be the case. As shown in Figure 6K-N, higher than normal numbers of TuJ1+ neurons were detected in the brains of early Gpc1-/- embryos. This effect was especially pronounced at E9.5, when there were over twice as many differentiated neurons in the fore- and midbrains of Gpc1 mutants as in wild-type animals (P < 0.005). To confirm that surplus TuJ1+ neurons were the progeny of cells that had recently undergone cell division, we pulsed embryos at E8.5 with the S-phase label 5-bromo-2'-deoxyuridine (BrdU), and one day later (E9.5) counted the number of TuJ1+/BrdU+ cells in the developing brain. In wild-type embryos we observed an average of 50 +/- 3 such cells per mm2, whereas in Gpc1-/- embryos we observed three times as many (150 +/- 49; P < 0.05).
###end p 42
###begin p 43
###xml 223 228 223 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G</xref>
###xml 737 738 737 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
###xml 785 789 785 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G,H</xref>
Not only do these results support the conclusion that FGF signaling is the main target of Gpc1 in the early central nervous system, they also explain the unexpectedly large, prolonged decreases in mitotic labeling index in Gpc1 mutant embryos (Figure 4G). This is because the labeling index represents the ratio of cells in M phase to total cells. When cells leave the cell cycle, they no longer affect the numerator of this ratio, but still contribute to its denominator, thereby causing an alteration in the labeling index that outlasts, for a period of time, any actual disturbance in the proliferative or differentiative behavior of cells (for a quantitative treatment of this point, see the Supplemental Appendix in Additional file 6). In short, the labeling index data in Figure 4G,H correspond well with the expected consequences of a temporary diminution in activity of a factor, such as FGF, that suppresses the differentiation of neuronal progenitors.
###end p 43
###begin title 44
Glypican-1 acts through Fgf17
###end title 44
###begin p 45
###xml 193 195 193 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 380 388 380 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nes-Ext1</italic>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">null </italic>
###xml 388 393 388 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>null </italic></sup>
###xml 426 431 426 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8 </italic>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
Several FGF family members have been implicated in brain development, with the subfamily formed by Fgf8, Fgf17 and Fgf18 having been shown to be especially important at early embryonic stages [44,45,47,62-64]. Fgf8, the most intensively studied of the group, plays critical roles in brain patterning and morphogenesis, and it has been suggested that some of the phenotypes in the Nes-Ext1null brain are the result of impaired Fgf8 function [39]. However, there is substantial overlap in expression of all three of these Fgfs, which also share similar receptor binding properties, and are all thought to control neural proliferation [65-67].
###end p 45
###begin p 46
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 53 55 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 63 67 63 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 63 67 63 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>neo </italic></sup>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8 </italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 367 372 367 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17</italic>
###xml 372 376 372 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 414 419 414 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 435 439 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C-F</xref>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 497 498 497 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 499 504 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17</italic>
###xml 504 506 504 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 531 532 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 376 380 <span type="species:ncbi:10090">mice</span>
In initial studies of compound mutants involving Gpc1- and Fgf8neo (a hypomorphic allele of Fgf8), we failed to observe significant genetic interaction (that is, a mutant allele of Fgf8 did not further reduce brain weight in a Gpc1 mutant; data not shown). In contrast, we were struck by similarities between the reported defects in anterior cerebellar patterning in Fgf17-/- mice [66] and those reported here for Gpc1 mutants (Figure 3C-F). We therefore generated and analyzed a set of adult Gpc1-;Fgf17- compound mutants (Figure 7).
###end p 46
###begin p 47
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 24 29 24 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17</italic>
###xml 0 29 0 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Gpc1 </italic>phenotypes require <italic>Fgf17</italic></bold>
###xml 40 44 40 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 45 51 45 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17 </italic>
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 96 99 96 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 100 105 100 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17</italic>
###xml 105 109 105 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 115 121 115 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-E) </bold>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 288 292 288 292 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 296 301 296 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17</italic>
###xml 301 305 301 305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 386 391 386 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17</italic>
###xml 391 395 391 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 415 419 415 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 419 422 419 422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 423 428 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17</italic>
###xml 428 432 428 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17</italic>
###xml 481 485 481 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 496 500 496 500 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(F) </bold>
###xml 760 765 760 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 768 774 768 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17 </italic>
###xml 864 869 864 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 905 907 905 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 918 920 918 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 942 943 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
Gpc1 phenotypes require Fgf17. Compound Gpc1/Fgf17 genotypes were produced by interbreeding Gpc1+/-;Fgf17+/- mice. (A-E) Nissl-stained mid-sagittal sections through the cerebella of adult compound mutants. Red arrowheads mark the anterior-most lobe (lobe I), which disappears in both Gpc1-/- and Fgf17-/- animals. Red arrows mark the fusion of lobes III and IV, a phenotype observed in Fgf17-/- mice. Note that the Gpc1-/-;Fgf17-/- phenotype is no more severe than the single Fgf17-/- phenotype. (F) Fresh brain weights of adult compound mutants. Genotypes for each category are as indicated; 'N' refers to the number of animals obtained of each genotype. The data show that, on their own, the presence of either one or two copies of mutant alleles for either Gpc1 or Fgf17 progressively reduces brain size. When animals are null for Fgf17, the presence of mutant Gpc1 alleles has no significant effect (*P < 0.005; **P < 0.001; by Student's t-test).
###end p 47
###begin p 48
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A-E</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7F</xref>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 272 278 272 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17 </italic>
###xml 431 437 431 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17 </italic>
###xml 480 485 480 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 564 569 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17</italic>
###xml 579 584 579 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 696 701 696 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 743 749 743 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17 </italic>
Representative midline cerebellar morphologies of animals of various compound genotypes are shown in Figure 7A-E. Figure 7F summarizes the distributions of brain weights among the entire collection, by genotype. The data clearly show that, as with Gpc1, loss of wild-type Fgf17 alleles leads to a progressive reduction in brain size and anterior cerebellar defects. Moreover, in animals that possessed either one or two functional Fgf17 alleles, the additional loss of one or two Gpc1 alleles led to a further reduction in brain size. However, in animals null for Fgf17, loss of Gpc1 had no significant phenotypic effect, either on brain size or cerebellar morphology. Complete dependence of the Gpc1 phenotype on the presence of a functional Fgf17 gene provides strong evidence that Fgf17 is, if not the only FGF through which Gpc1 acts, certainly among the most important, at least with respect to the control of brain size and cerebellar patterning.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 569 570 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 691 695 691 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 695 699 695 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 826 831 826 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 699 703 <span type="species:ncbi:10090">mice</span>
The data presented here establish that Gpc1 plays a role in controlling brain size by regulating the behavior of progenitor cells during early brain development. Although the quantitative effect of Gpc1 loss is modest - a 20% decrease in cell number - it is highly significant when compared to normal variation in brain size within genetically homogeneous mice (Figure 2). The effect appears to be due to a shift in the balance of progenitor cell proliferation versus differentiation over the course of approximately one day of development - from E8.5 to E9.5 (Figures 4 and 6). Diminished signaling by FGFs, but not other growth factors, could be demonstrated at around this time period in Gpc1-/- mice (Figure 6). Genetic epistasis experiments strongly suggested that reduced Fgf17 signaling accounts for most or all of the Gpc1 mutant phenotypes observed here.
###end p 50
###begin p 51
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 239 240 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 241 245 241 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 245 250 245 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </sup>
###xml 378 379 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 437 444 437 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus</italic>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 437 444 <span type="species:ncbi:8355">Xenopus</span>
The transient and modest effects of Gpc1 loss raised the possibility of either compensation by, or redundancy with, other HSPGs, and although no evidence for compensatory up-regulation of other core proteins was obtained, studies with Gpc1-;Gpc4LacZ double mutants suggested that Gpc1 and Gpc4 may have at least partially overlapping functions in controlling brain size (Figure 5). This idea is lent further support by recent studies in Xenopus, in which morpholino-mediated knockdown of Gpc4 led to a reduction in size of dorsal forebrain structures [68].
###end p 51
###begin p 52
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 26 30 26 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 113 125 113 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nestin1-Cre </italic>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ext1</italic>
###xml 294 303 294 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nes1-Ext1</italic>
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">null </italic>
###xml 303 308 303 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>null </italic></sup>
###xml 555 559 555 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 559 563 559 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 620 629 620 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nes1-Ext1</italic>
###xml 629 634 629 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">null </italic>
###xml 629 634 629 634 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>null </italic></sup>
###xml 703 707 703 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 707 709 707 709 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 713 717 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 717 722 717 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </sup>
###xml 730 731 730 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 734 738 734 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2</italic>
###xml 738 740 738 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 748 749 748 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 754 758 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc5</italic>
###xml 758 760 758 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 813 822 813 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nes1-Ext1</italic>
###xml 822 827 822 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink">null </italic>
###xml 822 827 822 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>null </italic></sup>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 185 190 <span type="species:ncbi:10090">mouse</span>
###xml 308 313 <span type="species:ncbi:10090">mouse</span>
###xml 563 568 <span type="species:ncbi:10090">mouse</span>
###xml 634 639 <span type="species:ncbi:10090">mouse</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
It is noteworthy that Gpc1-/- mice failed to display any of the severe developmental phenotypes reported for the Nestin1-Cre mediated conditional inactivation of Ext1, which produces a mouse in which all heparan sulfate is eliminated from the brain from about E10 onward. The phenotypes of the Nes1-Ext1null mouse include specific hypoplasia of the cerebral hemispheres, absence of the cerebellum and olfactory bulbs, and loss of certain midline commissural tracts. It is possible that the mild deficits in the anterior cerebellum that we observed in the Gpc1-/- mouse are related to the cerebellar agenesis seen in the Nes1-Ext1null mouse. Interestingly, even when double mutant mice were made between Gpc1- and Gpc4LacZ (Figure 5), Gpc2- (Figure 5) or Gpc5- (YHJ, ADL and S Saunders, unpublished observations), Nes1-Ext1null phenotypes were not observed. It may be that the combined loss of function of multiple glypicans, and/or glypicans as well as syndecans (the other major family of HSPGs), is required to substantially eliminate heparan sulfate function in brain development.
###end p 52
###begin p 53
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 205 207 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B79">79</xref>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 312 316 312 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 506 511 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 515 521 515 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17 </italic>
###xml 529 530 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 566 575 566 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nes1-Ext1</italic>
###xml 575 580 575 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">null </italic>
###xml 575 580 575 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>null </italic></sup>
###xml 717 719 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B80">80</xref>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B81">81</xref>
###xml 807 813 807 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ndst1 </italic>
###xml 877 879 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B82">82</xref>
###xml 880 882 880 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B83">83</xref>
###xml 919 926 919 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 316 321 <span type="species:ncbi:10090">mouse</span>
###xml 580 585 <span type="species:ncbi:10090">mouse</span>
###xml 820 824 <span type="species:ncbi:10090">mice</span>
The growth factor families that have been shown to utilize HSPGs as co-receptors include FGFs, BMPs, Hedgehogs and Wnts [1,3,5,44,69-73] - all of which play important roles during early brain development [74-79]. It was surprising, therefore, that evidence only for reduced FGF signaling was obtained in the Gpc1-/- mouse. Such evidence included reduced expression of FGF target genes, decreased basal Erk activation, and premature neuronal differentiation (Figure 6), as well as genetic epistasis between Gpc1 and Fgf17 (Figure 7). Several of the phenotypes in the Nes1-Ext1null mouse are also consistent with reduced FGF signaling, including cerebellar and olfactory bulb agenesis and cerebral cortical hypoplasia [64,66,80,81]. Diminished FGF signaling has also been implicated in the lens phenotypes in Ndst1 mutant mice (which produce aberrantly sulfated heparan sulfate [82,83]). These observations suggest that, in vivo, FGF signaling may be an especially sensitive indicator of deficits in HSPG function.
###end p 53
###begin p 54
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 170 171 170 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 206 211 206 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B84">84</xref>
A fascinating aspect of the Gpc1 mutant phenotype is that the brain weight of heterozygous animals falls halfway between that of wild type and homozygous mutants (Figure 2). This implies that the amount of Gpc1 expressed by cells influences, in a continuous fashion, the level of growth factor signaling that cells perceive. In other words, Gpc1 may not merely be necessary for growth factor signaling, but a quantitative regulator of the 'gain' of signaling. Accordingly, regulation of Gpc1 expression may be an important part of the control circuitry that keeps brain size so tightly regulated in mammals [37,84].
###end p 54
###begin p 55
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc3 </italic>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc3 </italic>
###xml 285 286 285 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 287 288 287 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B86">86</xref>
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc3 </italic>
###xml 446 451 446 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc3 </italic>
###xml 535 540 535 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc3 </italic>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B85">85</xref>
###xml 865 876 865 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 932 934 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B87">87</xref>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B89">89</xref>
###xml 101 106 <span type="species:ncbi:10090">Mouse</span>
###xml 273 278 <span type="species:ncbi:9606">human</span>
###xml 865 875 <span type="species:ncbi:7227">Drosophila</span>
Recent work suggests a similar quantitative role - albeit in the opposite direction - for Gpc3 [85]. Mouse Gpc3 mutants are known to display marked pre- and postnatal overgrowth of many organs, phenocopying Simpson Golabi Behmel syndrome (a syndrome caused by mutations in human GPC3 [8,9,86]). Because Gpc3 is on the X chromosome, gene dosage effects are not observable with null alleles, but studies of naturally occurring polymorphisms in the Gpc3 regulatory region have recently implied that quantitative variation in the level of Gpc3 expression directly (negatively) controls body size [85]. Even though the molecular mechanism of somatic growth inhibition by Gpc3 is likely to differ from the mechanism of brain growth promotion by Gpc1, the implication of both glypicans in quantitative regulation of size is striking. Intriguingly, a variety of studies in Drosophila also link invertebrate glypicans to organ size control [87-89].
###end p 55
###begin p 56
###xml 140 142 140 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 206 210 206 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 424 426 424 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B90">90</xref>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B92">92</xref>
###xml 462 473 462 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B89">89</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B93">93</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B95">95</xref>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B96">96</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B97">97</xref>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B98">98</xref>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B99">99</xref>
###xml 1037 1042 1037 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 210 215 <span type="species:ncbi:10090">mouse</span>
###xml 462 472 <span type="species:ncbi:7227">Drosophila</span>
###xml 672 675 <span type="species:ncbi:9606">man</span>
###xml 1049 1054 <span type="species:ncbi:10090">mouse</span>
The present study leaves unresolved the role that glypicans play in axons and nerve terminals, where Gpc1 and Gpc2 are especially abundant [36]. The absence of obvious defects in axonal pathways in the Gpc1-/- mouse suggests that these molecules may play more of a role in synaptic physiology than in axonal growth or guidance. Certainly, evidence for the participation of syndecan-2 and syndecan-3 in synapse formation [14,90-92], as well as recent work on the Drosophila nervous system [89,93-95], suggests that HSPGs may play a variety of as yet unappreciated roles in basic neurophysiology. To this end, it is intriguing that recent genome-wide association studies in man have identified both GPC1 and FGFR2 (which encodes a major FGF receptor of the brain) as members of a small handful of genetic loci that correlate with risk of schizophrenia [96,97], a psychiatric disorder also associated with a small, but significant, reduction in brain volume [98,99]. Clearly, a detailed behavioral and neurophysiological examination of the Gpc1 mutant mouse seems warranted in the future.
###end p 56
###begin title 57
Conclusion
###end title 57
###begin p 58
Cell-surface HSPGs are critical for growth and patterning in numerous tissues and organ systems, presumably as a consequence of their actions as growth factor co-receptors. Here we show that Gpc1 controls the size of the mammalian brain through an unexpectedly specific mechanism: regulation of the proliferation/differentiation behavior of progenitor cells during a very early stage of neurogenesis. We provide evidence that this action is mediated through regulation of Fgf17 signaling, and further show that Gpc1's effects are gene-dosage dependent. The data support the view that glypicans, and possibly HSPGs in general, serve as quantitative regulators of the gain of growth factor signaling during neural development.
###end p 58
###begin title 59
Materials and methods
###end title 59
###begin title 60
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 60
###begin p 61
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 4 6 4 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 100 109 100 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">inter se </italic>
###xml 176 180 176 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 180 182 180 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
Gpc1- heterozygous mutants were bred extensively onto CD1 and C57BL/6 backgrounds prior to breeding inter se to produce homozygous mutant animals. PCR primers specific for the Gpc1- allele were 5'-AGCCGGCTTTTGTTGTCTC-3' and 5'-CACGAGTGTGCTAGGATAGGG-3'. Primers specific for the Gpc1 wild-type allele were 5'-CAGCGAAGTCCGCCAGAT-3' and 5'-CAGACCTCCCGAGTGCTAGG-3'.
###end p 61
###begin p 62
###xml 86 91 86 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 152 157 152 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4 </italic>
###xml 191 194 191 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B100">100</xref>
###xml 195 198 195 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B101">101</xref>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2 </italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf2 </italic>
###xml 344 349 344 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8 </italic>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">neo </italic>
###xml 354 358 354 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>neo </italic></sup>
###xml 359 362 359 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B102">102</xref>
###xml 366 372 366 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17 </italic>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 436 439 436 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B103">103</xref>
###xml 469 473 <span type="species:ncbi:10090">mice</span>
The following additional mutant alleles were used in this study: gene-trap alleles of Gpc1 (GPC1lacZ; Baygenomics ID GST062 San Francisco, CA, USA) and Gpc4 (GPC4lacZ; Baygenomics ID Ex194) [100,101]; a targeted null mutation in Gpc2 (S Saunders and ADL, unpublished); Fgf2 (Jackson Laboratory, Bar Harbor, Maine, USA), a hypomorphic allele of Fgf8 (Fgf8neo [102]), Fgf17 ([74]) and a LacZ-reporter of canonical Wnt signaling (Bat-gal [103]). Wild type CD1 and C57BL/6 mice were from Charles River (San Diego, CA, USA) Genotypes were determined by PCR of tail DNA.
###end p 62
###begin p 63
###xml 240 244 <span type="species:ncbi:10090">mice</span>
For production of staged embryos, timed matings were used and noon of the day of vaginal plug was considered as E0.5. At early embryonic stages, more precise staging was obtained from somite number. To obtain BrdU-labeled embryos, pregnant mice were injected intraperitoneally with 50 mug of BrdU (B5002; Sigma-Aldrich St. Louis, MO, USA)per gram body weight and embryos were collected 24 hours later.
###end p 63
###begin p 64
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse colonies were maintained, and all animal experimentation conducted, in accordance with the policies and guidelines of the Institutional Animal Care and Use Committee (IACUC) of the University of California, Irvine. (IACUC protocol number 1998-1656).
###end p 64
###begin title 65
Histology and histochemistry
###end title 65
###begin p 66
###xml 680 682 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1621 1624 1583 1586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B104">104</xref>
###xml 525 529 <span type="species:ncbi:9925">goat</span>
###xml 541 547 <span type="species:ncbi:9913">bovine</span>
###xml 692 698 <span type="species:ncbi:9986">rabbit</span>
###xml 912 916 <span type="species:ncbi:9925">goat</span>
###xml 922 928 <span type="species:ncbi:9986">rabbit</span>
###xml 954 958 <span type="species:ncbi:9925">goat</span>
###xml 964 969 <span type="species:ncbi:10090">mouse</span>
###xml 990 994 <span type="species:ncbi:9925">goat</span>
###xml 1000 1005 <span type="species:ncbi:10090">mouse</span>
###xml 1070 1074 <span type="species:ncbi:9925">goat</span>
###xml 1080 1083 <span type="species:ncbi:10116">rat</span>
Adult brains were fast-frozen in 2-methyl-butane prior to cryomicrotome sectioning at 20 mum. Embryos were dissected in cold phosphate-buffered saline (PBS), fixed in 4% paraformaldehyde in PBS at 4degreesC overnight, cryoprotected in 30% sucrose in PBS at 4degreesC, and cryomicrotome sectioned at 10 to 20 mum. Sections were stored at -20degreesC prior to immunohistochemistry or Cresyl-Violet staining. For BrdU staining, cryosections were treated with 2 M HCl for 1 hour at 37degreesC. Sections were then blocked with 5% goat serum +10% bovine serum albumin/PBS +0.2% Tween20 and incubated with primary antibody diluted in blocking solution at 4degreesC overnight (anti-Gpc1 [27], 1:500; rabbit anti-phosphohistone H3 (anti-PHH3; Millipore, Billerica, MA, USA, 5 mug/ml, 1:500; Tuj1 (R&D systems, 1:1,000, Minneapolis, MN, USA); anti-BrdU (Abcam, 1:100, Cambridge, MA, USA). Secondary antibodies (alexaFluor goat anti-rabbit IgG, 2 mug/ml alexaFluor goat anti-mouse IgG, 10 mug/ml; Cy3-goat anti mouse, 7 mug/ml (Jackson Immunoresearch, West Grove, PA, USA); or Cy2-goat anti rat, 14 mug/ml (Jackson Immunoresearch)) were applied for 1 hour at room temperature. For quantification of apoptosis, fluorescent TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assays (Apotag Kit, Serologicals, Norcross, GA, USA) were performed on cyrosections. Hoechst33258 was used at 2 mug/ml for nuclear counterstaining. Fluorescence images were analyzed with a Ziss Axiovert S100 microscope and Hamamatsu C4742-95 digital camera. Wholemount staining for beta-galactosidase activity was performed as described in [104].
###end p 66
###begin title 67
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
In situ hybridization
###end title 67
###begin p 68
###xml 159 167 153 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 209 212 203 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B105">105</xref>
###xml 504 508 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 575 579 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc2</italic>
###xml 640 644 634 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc3</italic>
###xml 713 717 707 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 786 790 780 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc5</italic>
###xml 851 855 845 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc6</italic>
E8.5-E9.5 embryos, fixed by immersion in 4% paraformaldehyde, were gradually dehydrated in methanol and stored in 100% methanol at -20degreesC. Wholemount RNA in situ hybridization was performed as described [105] with probes synthesized using digoxigenin-labeled NTP mix (Roche, Indianapolis, IN, USA). Probes for glypicans (Glypicans 1 to 6) were obtained by RT-PCR from E13.5 brain total RNA, using the following primer pairs, and subcloned into the PCRII-TOPO vector (Invitrogen, Carlsbad, CA, USA): Gpc1, 5'-GCTACATCTCCATCTTCCTTGAC-3' and 5'-AACACACATTATCCACTGACACC-3'; Gpc2, 5'-AGTCTGGCGAGGGGTTAGAT-3' and 5'-GGCTACATTGAGGCAGAAGC-3'; Gpc3, 5'-GGATGGTGAAAGTGAAGAATCAAC-3' and 5'-GAGAGAAAGAGAAAAGAGGGAAAC-3'; Gpc4, 5'-CATGGCACGCTTAGGCTTGCTCGC-3' and 5'-TGGTTGCACTGTTCGCTGACCACG-3'; Gpc5, 5'-CGCCAGGATGTTAGTCCATT-3' and 5'-AATTTCTGCCCATTGAGGTG-3'; Gpc6, 5'-GCTGTGTATTCTTGCTCTCTCCGGG-3' and 5'-GTACAGCATCCCGTAGGTCCGGAC-3'.
###end p 68
###begin p 69
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pax6 </italic>
###xml 79 85 79 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry2 </italic>
###xml 101 104 101 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B106">106</xref>
###xml 108 114 108 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pyst1 </italic>
###xml 130 133 130 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B107">107</xref>
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ptc1 </italic>
###xml 158 161 158 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B108">108</xref>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msx1 </italic>
###xml 171 174 171 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Eco</italic>
###xml 225 233 225 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
The following additional RNA probes were used: Pax6 (335 to 595 bp MN_013627), Spry2 (probe used in [106]), Pyst1 (probe used in [107]), Ptc1 (probe used in [108]), Msx1 (EcoRI fragment from IMAGE clone 903377). Controls for in situ hybridization consisted of sense probes derived from the same DNA fragments.
###end p 69
###begin title 70
Measurement of brain size and DNA content
###end title 70
###begin p 71
Postnatal and adult brains were freshly dissected. After removal of olfactory bulbs and remaining spinal cord (at the level of the posterior margin of the cerebellum), brains were immediately weighed on a laboratory scale.
###end p 71
###begin p 72
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 474 477 474 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B109">109</xref>
###xml 750 753 750 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3/2</sup>
Images of fresh embryos were collected using a Leica MZFLIII stereomicroscope and a SPOT camera (Diagnostic Instruments, Inc. Sterling Heights, MI, USA). For embryos at E11.5 or older, brain height, depth and width were separately measured from lateral and frontal images (Additional file 2), and multiplied to produce a volume estimate. For E8.5 and E9.5 embryos, measurements of area were obtained from perimeter tracings of lateral views using Image J analysis software [109]. At these stages the central nervous system comprises the majority of head tissue, so such tracings included the entire head, stopping ventrally at the rostral border of the first branchial arch, and dorsally at the top of mesencephalon. Volume was then estimated as area3/2. In some cases, volume was also estimated by the procedures outlined above for older embryos, and qualitatively similar results were obtained.
###end p 72
###begin p 73
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
DNA content in brain homogenates was measured by enhancement of bisbenzimid fluorescence at 458 nm, as described by Labarca and Paigen [38]. A linear standard curve (1 to 10 mug/ml) was obtained using salmon sperm DNA (Invitrogen).
###end p 73
###begin title 74
Quantitative RT-PCR
###end title 74
###begin p 75
###xml 475 478 475 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B110">110</xref>
###xml 479 482 479 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B111">111</xref>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Forebrain vesicles of E9.5 and E8.5 wild-type and mutant mice were dissected in ice-cold PBS, and RNA was isolated and column purified (Aurum Total RNA Mini Kit, Bio-Rad, Herculeus, CA, USA) according to the manufacturer's instructions. cDNA was generated by reverse transcription with a mixture of oligo dT and random hexamers (Superscript First-Strand Synthesis kit, Invitrogen). PCR quality controls, experimental runs and statistical methods were performed as described [110,111]. Quantification of total mRNA expression was performed with an Opticon System (MJ Systems CFD-3200, Calgary, Denver, USA) and SYBR-Green (Bio-Rad).
###end p 75
###begin p 76
###xml 222 223 222 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 334 351 330 347 <sub xmlns:xlink="http://www.w3.org/1999/xlink">gene of interest </sub>
###xml 355 369 351 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink">reference(18S)</sub>
###xml 414 428 410 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-&#916;&#916;Ct </sup>
###xml 458 465 434 441 <sub xmlns:xlink="http://www.w3.org/1999/xlink">mutant </sub>
###xml 474 484 446 456 <sub xmlns:xlink="http://www.w3.org/1999/xlink">wild-type </sub>
###xml 485 488 457 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B112">112</xref>
###xml 569 583 529 535 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-&#916;&#916;Ct </sup>
All measurements were normalized to values for 18S RNA in the same samples. All cDNA samples were validated for reverse transcription reaction efficiency and minimal genomic DNA contamination (cDNA/genomic target ratio >105) for 40 cycles in duplicates. Average of duplicated cycle threshold (Ct) values were normalized as DeltaCt (Ctgene of interest - Ctreference(18S)). Relative levels were converted using the 2-DeltaDeltaCt method: DeltaDeltaCt = DeltaCtmutant - DeltaCtwild-type [112] Averages of duplicate Ct, normalized DeltaCt, DeltaDeltaCt and relative level 2-DeltaDeltaCt and standard errors were calculated using Microsoft Excel.
###end p 76
###begin title 77
Measurement of Erk activity in embryonic explant cultures
###end title 77
###begin p 78
###xml 87 90 87 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B110">110</xref>
###xml 557 558 546 547 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 560 561 549 550 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 717 726 700 709 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1194 1197 1176 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B113">113</xref>
E9.5 dorsal telencephalon explants were isolated and cultured as previously described [110]. After 1 hour of incubation at 37degreesC, FGF2 (R&D Systems) was added at the concentrations indicated for 15 minutes. Explants were briefly washed with 1x PBS and individually homogenized in lysis buffer (1 mM EGTA, 1% Triton X-100, 150 mM NaCl, 50 mM Tris-Cl pH7.4, 1% NP40, 1 mug/ml phenylmethylsulphonyl fluoride (PMSF), 1 mug/ml leupeptin, 1 mug/ml pepstatin, 1 mug/ml aprotinin, 25 mug/ml N-ethylmaleimide (NEM), and phosphatase inhibitors (1 mM NaF, 1 mM Na3VO4)) with a disposable pestle (Knotes Scientific, Vineland, NJ, USA) Lysed samples were stored at -80degreesC until use. Erk activity was quantified using an in vitro phosphorylation assay (MAP Kinase/Erk Assay kit; Upstate Biotechnology) following the manufacturer's instructions, with or without the 20 muM Erk inhibitor FR180204 (Calbiochem, Gibbstownm, NJ, USA) treatment for 10 minutes prior to the assay. Values in the presence of FR180204 were taken to represent non-ERK phosphorylation activity, and subtracted from each data point. Data were normalized to protein concentration determined by a bicinchoninic acid (BCA) assay [113].
###end p 78
###begin title 79
Subcellular fractionation and analysis of proteoglycan content
###end title 79
###begin p 80
###xml 128 131 128 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B114">114</xref>
###xml 835 841 <span type="species:ncbi:9986">rabbit</span>
###xml 880 885 <span type="species:ncbi:10090">mouse</span>
###xml 1085 1096 <span type="species:ncbi:3704">horseradish</span>
###xml 1119 1123 <span type="species:ncbi:9925">goat</span>
###xml 1129 1135 <span type="species:ncbi:9986">rabbit</span>
###xml 1139 1145 <span type="species:ncbi:9793">donkey</span>
###xml 1151 1156 <span type="species:ncbi:10090">mouse</span>
Adult brains were dissected in ice-cold PBS and immediately homogenized. to obtain membrane and soluble fractions as described [114]. For SDS-PAGE analysis, samples prepared in this way were digested for 30 minutes at 37degreesC with Heparinase III or with Heparinase III plus Chondroitinase ABC (all used at 1.5 U/mg of protein; both enzymes were purchased from Seikagaku Corp., Tokyo, Japan) along with a proteinase inhibitor mixture (10 mug/ml pepstatin A, 20 mug/ml leupeptin, 2.5 mg/ml NEM, and PMSF in 50 mM Tris-hydroxyaminomethane, 15 mM phosphoric acid, pH7.3). Digested samples were boiled for 10 minutes in SDS-PAGE sample buffer and loaded at 50 mug protein per lane onto 7.5% SDS-polyacrylamide gels, and subjected to electrophoresis. Gels were transferred to PVDF membrane (Millipore, Billerica, MA, USA) and probed with rabbit anti-glypican-1 (1:3,000) antibody or mouse 3G10 monoclonal antibody (1:2,000; USBiological, Swampscott, MA, USA). Samples without enzyme treatment, or subjected to single enzyme treatment, were used where indicated. Blots were incubated with horseradish peroxidase-conjugated goat anti-rabbit or donkey anti-mouse antibody, as appropriate, and visualized using enhanced chemiluminescence.
###end p 80
###begin title 81
Abbreviations
###end title 81
###begin p 82
###xml 276 280 276 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry</italic>
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sprouty</italic>
BMP: bone morphogenetic protein; BrdU: 5-bromo-2'-deoxyuridine; E: embryonic day; ERK: extracellular regulated kinase; ES: embryonic stem; FGF: fibroblast growth factor; Gpc: glypican; HSPG: heparan sulfate proteoglycan; MAP: mitogen-activated protein; NEM: N-ethylmaleimide; Spry: Sprouty; PBS: phosphate-buffered saline; PHH3: phosphohistone H3; PMSF: phenylmethylsulphonyl fluoride.
###end p 82
###begin title 83
Competing interests
###end title 83
###begin p 84
The authors declare that they have no competing interests.
###end p 84
###begin title 85
Authors' contributions
###end title 85
###begin p 86
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1 </italic>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
YHJ and ADL conceived of the studies, designed the experiments, interpreted the data and wrote the manuscript. YHJ carried out the experiments, except for the generation of Gpc1 knockout mice, which was carried out by MM.
###end p 86
###begin title 87
Supplementary Material
###end title 87
###begin title 88
Additional file 1
###end title 88
###begin p 89
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 45 49 45 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Morphometric comparison of wild-type and <italic>Gpc1</italic><sup>-/- </sup>forebrains</bold>
###xml 499 503 499 503 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 697 701 697 701 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 797 801 797 801 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 1869 1870 1869 1870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 555 559 <span type="species:ncbi:10090">mice</span>
Morphometric comparison of wild-type and Gpc1-/- forebrains. Freshly dissected adult brains were photographed from the dorsal surface. Tracings of the outline of the forebrain hemispheres were digitized and each curve converted to a series of points, in intervals of 0.03 radians, on a polar plot centered on its centroid. For each genotype, the curves from different brains were overlayed and rotated so that the medial edges of each tracing (which are relatively straight) were optimally aligned. (A) An example from the right hemisphere of nine mutant mice. An average curve was generated by calculating the average distance from the centroid for the family of curves at each angular position. (B) Curves representing one standard deviation above and below the average were similarly produced. (C) A single curve depicting the ratio of the average mutant and wild-type values at each angular position was then generated, and error bars around this curve were calculated from the square root of the sum of the squares of the relative errors (standard deviation/mean) for the two mutant and wild-type average curves; the comparison of nine mutant and four wild-type right hemispheres using this process is shown. The null hypothesis - that mutant and wild-type forebrains are identical in shape - implies that the ratio curve should be a perfect circle (that is, distance to the centroid for mutant and wild-type should differ by the same proportion at every angular position). As shown in (C), a circle (r = 0.937) fit within the error bars at every angular position, implying that mutant forebrains are approximately 6.3% smaller in linear dimension, with no significant difference in forebrain shape. Note that a 6.3% decrease in linear dimension is consistent with an 18% decrease in volume, comparable to the observed 15.5% decrease in total brain weight (Figure 2).
###end p 89
###begin p 90
Click here for file
###end p 90
###begin title 91
Additional file 2
###end title 91
###begin p 92
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Approaches used for estimation of brain volumes of embryos</bold>
###xml 111 115 111 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 121 125 121 125 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 134 138 134 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
Approaches used for estimation of brain volumes of embryos. Approaches used for estimation of brain volumes of (A) E8.5, (B) E9.5 and (C) E11.5 embryos. Outlines of the primarily neural regions of the head were traced on lateral images of E8.5 to E9.5 embryos, and the enclosed area calculated. At E11.5, separate measurements were made of depth (green line in (C), running from the midbrain-hindbrain boundary (MHB) to the upper nasal-facial junction), height (blue line in (C) connecting the midbrain-forebrain boundary (MFB) to the upper jaw), and width (interocular distance, measured from a frontal view; not shown).
###end p 92
###begin p 93
Click here for file
###end p 93
###begin title 94
Additional file 3
###end title 94
###begin p 95
###xml 0 89 0 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Evaluation of cell proliferation in wild-type (+/+) and Gpc1 mutant (-/-) embryos at E9.5</bold>
###xml 91 97 91 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-F) </bold>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G,H</xref>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 336 339 336 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 378 382 378 382 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(G) </bold>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 527 531 527 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Evaluation of cell proliferation in wild-type (+/+) and Gpc1 mutant (-/-) embryos at E9.5. (A-F) Sagittal sections of E9.5 embryos were immunostained for phosphohistone H3 (PHH3) (A, D), counterstained with bizbenzamide (B, E) and the two images merged (C,F). As quantified in Figure 4G,H, there are fewer PHH3 labeled cells in the Gpc1-/-neuroepithelium than in the wild type. (G) However, as shown here, the PHH3 labeling index specifically in non-neuroepithelial areas of the head is not significantly different between Gpc1-/- and wild-type embryos.
###end p 95
###begin p 96
Click here for file
###end p 96
###begin title 97
Additional file 4
###end title 97
###begin p 98
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 83 87 83 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 127 0 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Lack of apparent difference in Sonic hedgehog, BMP and Wnt signal intensity in <italic>Gpc1</italic><sup>-/- </sup>during early stages of brain development</bold>
###xml 129 135 129 135 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A-J) </bold>
###xml 147 155 147 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 235 239 235 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 239 243 239 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 427 435 427 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 453 461 453 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Patched1</italic>
###xml 501 509 501 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
###xml 527 531 527 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msx1</italic>
###xml 772 777 772 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Msx1 </italic>
###xml 789 797 789 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
Lack of apparent difference in Sonic hedgehog, BMP and Wnt signal intensity in Gpc1-/- during early stages of brain development. (A-J) Whole mount in situ hybridization and reporter gene expression in E8.5 and E9.5 wild type (+/+) and Gpc1-/- (-/-) embryos were used to assess levels and distribution of activity of the Hedgehog, BMP and Wnt signaling pathways, all of which have been reported to be influenced by HSPGs. (A-D) In situ hybridization for Patched1, a marker of Hedgehog signaling. (E-H) In situ hybridization for Msx1, a marker for BMP signaling. Those small differences in staining intensity that are visible in these images (for example, in the anterior hindbrain) were not consistent findings, but reflect a high degree of embryo-to-embryo variability in Msx1 whole mount in situ hybridization. (I-J) beta-galactosidase activity in embryos crossed onto a BAT-gal background, in which LacZ expression reports canonical Wnt signaling.
###end p 98
###begin p 99
Click here for file
###end p 99
###begin title 100
Additional file 5
###end title 100
###begin p 101
###xml 12 20 12 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 38 44 38 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry2 </italic>
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Whole mount <italic>in situ </italic>hybridization for <italic>Spry2 </italic>at E10.25</bold>
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6E-H</xref>
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Spry2 </italic>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 156 160 156 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 271 275 271 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Whole mount in situ hybridization for Spry2 at E10.25. When compared with Figure 6E-H, the data suggest that Spry2 expression returns to near-normal in Gpc1-/- embryos by E10.25. These observations are consistent with the view that the disruption of Fgf signaling in Gpc1-/- embryos is transient.
###end p 101
###begin p 102
Click here for file
###end p 102
###begin title 103
Additional file 6
###end title 103
###begin p 104
###xml 0 90 0 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Supplemental appendix: models for the effect of Gpc1 deficiency on early brain development</bold>
Supplemental appendix: models for the effect of Gpc1 deficiency on early brain development. Supplemental appendix: models for the effect of Gpc1 deficiency on early brain development
###end p 104
###begin p 105
Click here for file
###end p 105
###begin title 106
Acknowledgements
###end title 106
###begin p 107
###xml 249 255 249 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf17 </italic>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fgf8</italic>
###xml 290 294 290 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">neo </sup>
###xml 355 359 355 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc1</italic>
###xml 359 364 359 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </sup>
###xml 368 372 368 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gpc4</italic>
###xml 372 377 372 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">LacZ </sup>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
We thank Felix Truong, Betty Yeh, and Karishima Datye for their excellent technical assistance and Edwin Monuki and Spencer Currle for their assistance in setting up forebrain explant and quantitative PCR assays. We thank David Ornitz for providing Fgf17 mice, Anne Calof for providing Fgf8neo mice, Maike Sander for BAT-gal mice, and William Skarnes for Gpc1LacZ and Gpc4LacZ mice. This work was supported by NIH grants R01-NS26862 and P50-GM076516.
###end p 107
###begin article-title 108
Functions of heparan sulfate proteoglycans in cell signaling during development
###end article-title 108
###begin article-title 109
Specificities of heparan sulphate proteoglycans in developmental processes
###end article-title 109
###begin article-title 110
Messages in the matrix: proteoglycans go the distance
###end article-title 110
###begin article-title 111
Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless
###end article-title 111
###begin article-title 112
Heparan sulfate proteoglycans exert positive and negative effects in Shh activity
###end article-title 112
###begin article-title 113
Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients
###end article-title 113
###begin article-title 114
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient in Ext2 lack heparan sulfate and develop exostoses
###end article-title 114
###begin article-title 115
glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development
###end article-title 115
###begin article-title 116
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome
###end article-title 116
###begin article-title 117
###xml 84 89 <span type="species:ncbi:10090">mouse</span>
Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse
###end article-title 117
###begin article-title 118
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Increased leukocyte-endothelial interactions in syndecan-1-deficient mice involve heparan sulfate-dependent and -independent steps
###end article-title 118
###begin article-title 119
Role of syndecan-1 in leukocyte-endothelial interactions in the ocular vasculature
###end article-title 119
###begin article-title 120
Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3
###end article-title 120
###begin article-title 121
###xml 21 25 <span type="species:ncbi:10090">mice</span>
Syndecan-3-deficient mice exhibit enhanced LTP and impaired hippocampus-dependent memory
###end article-title 121
###begin article-title 122
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4
###end article-title 122
###begin article-title 123
Syndecan-4 modulates focal adhesion kinase phosphorylation
###end article-title 123
###begin article-title 124
Heparan sulphate
###end article-title 124
###begin article-title 125
The emerging roles of cell surface heparan sulfate proteoglycans
###end article-title 125
###begin article-title 126
###xml 66 70 <span type="species:ncbi:10090">mice</span>
Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice
###end article-title 126
###begin article-title 127
Heparan sulfate proteoglycans and cancer
###end article-title 127
###begin article-title 128
Developmental roles of the glypicans
###end article-title 128
###begin article-title 129
Glypicans: proteoglycans with a surprise
###end article-title 129
###begin article-title 130
The role of glypicans in mammalian development
###end article-title 130
###begin article-title 131
Heparan sulfate core proteins in cell-cell signaling
###end article-title 131
###begin article-title 132
Heparan sulphate proteoglycans: the sweet side of development
###end article-title 132
###begin article-title 133
Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells
###end article-title 133
###begin article-title 134
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells
###end article-title 134
###begin article-title 135
###xml 85 88 <span type="species:ncbi:10116">rat</span>
Cloning of a major heparan sulfate proteoglycan from brain and identification as the rat form of glypican
###end article-title 135
###begin article-title 136
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
Immunocytochemical and in situ hybridization studies of the heparan sulfate proteoglycan, glypican, in nervous tissue
###end article-title 136
###begin article-title 137
Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation
###end article-title 137
###begin article-title 138
###xml 129 132 <span type="species:ncbi:10116">rat</span>
Neuronal expression of glypican, a cell-surface glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan, in the adult rat nervous system
###end article-title 138
###begin article-title 139
Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain
###end article-title 139
###begin article-title 140
Glypican-4 is an FGF2-binding heparan sulfate proteoglycan expressed in neural precursor cells
###end article-title 140
###begin article-title 141
K-glypican: a novel GPI-anchored heparan sulfate proteoglycan that is highly expressed in developing brain and kidney
###end article-title 141
###begin article-title 142
Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent
###end article-title 142
###begin article-title 143
Cerebroglycan, a developmentally regulated cell-surface heparan sulfate proteoglycan, is expressed on developing axons and growth cones
###end article-title 143
###begin article-title 144
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Mapping genes that modulate mouse brain development: a quantitative genetic approach
###end article-title 144
###begin article-title 145
A simple, rapid, and sensitive DNA assay procedure
###end article-title 145
###begin article-title 146
Mammalian brain morphogenesis and midline axon guidance require heparan sulfate
###end article-title 146
###begin article-title 147
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
Glypicans are differentially expressed during patterning and neurogenesis of early mouse brain
###end article-title 147
###begin article-title 148
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
An autoradiographic study of the generation cycle in the ten-day mouse embryo neural tube
###end article-title 148
###begin article-title 149
###xml 116 121 <span type="species:ncbi:10090">mouse</span>
Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos
###end article-title 149
###begin article-title 150
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
Expression pattern of glypican-4 suggests multiple roles during mouse development
###end article-title 150
###begin article-title 151
Embryonic signaling centers expressing BMP, WNT and FGF proteins interact to pattern the cerebral cortex
###end article-title 151
###begin article-title 152
Dose-dependent functions of Fgf8 in regulating telencephalic patterning centers
###end article-title 152
###begin article-title 153
The morphogen signaling network in forebrain development and holoprosencephaly
###end article-title 153
###begin article-title 154
Specific regions within the embryonic midbrain and cerebellum require different levels of FGF signaling during development
###end article-title 154
###begin article-title 155
Shedding light on the distinct functions of proteoglycans
###end article-title 155
###begin article-title 156
Fibroblast growth factors
###end article-title 156
###begin article-title 157
###xml 38 47 38 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
Genesis of olfactory receptor neurons in vitro : regulation of progenitor cell divisions by fibroblast growth factors
###end article-title 157
###begin article-title 158
###xml 166 171 <span type="species:ncbi:10090">mouse</span>
Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain
###end article-title 158
###begin article-title 159
Changes in cerebral cortex size are governed by fibroblast growth factor during embryogenesis
###end article-title 159
###begin article-title 160
###xml 38 41 <span type="species:ncbi:10116">rat</span>
Prospective cell sorting of embryonic rat neural stem cells and neuronal and glial progenitors reveals selective effects of basic fibroblast growth factor and epidermal growth factor on self-renewal and differentiation
###end article-title 160
###begin article-title 161
###xml 132 137 <span type="species:ncbi:10090">mouse</span>
Fibroblast growth factor receptor 1 is required for the proliferation of hippocampal progenitor cells and for hippocampal growth in mouse
###end article-title 161
###begin article-title 162
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
Fibroblast growth factor 2 is required for maintaining the neural stem cell pool in the mouse brain subventricular zone
###end article-title 162
###begin article-title 163
###xml 119 124 <span type="species:ncbi:10090">mouse</span>
Fgf8 expression defines a morphogenetic center required for olfactory neurogenesis and nasal cavity development in the mouse
###end article-title 163
###begin article-title 164
Self-renewing and differentiating properties of cortical neural stem cells are selectively regulated by basic fibroblast growth factor (FGF) signaling via specific FGF receptors
###end article-title 164
###begin article-title 165
Fibroblast growth factor receptors cooperate to regulate neural progenitor properties in the developing midbrain and hindbrain
###end article-title 165
###begin article-title 166
Fibroblast growth factor receptor 3 kinase domain mutation increases cortical progenitor proliferation via mitogen-activated protein kinase activation
###end article-title 166
###begin article-title 167
###xml 11 16 <span type="species:ncbi:10090">mouse</span>
Control of mouse myoblast commitment to terminal differentiation by mitogens
###end article-title 167
###begin article-title 168
Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor
###end article-title 168
###begin article-title 169
Regulation and function of FGF8 in patterning of midbrain and anterior hindbrain
###end article-title 169
###begin article-title 170
The isthmic organizer signal FGF8 is required for cell survival in the prospective midbrain and cerebellum
###end article-title 170
###begin article-title 171
Frontal cortex subdivision patterning is coordinately regulated by Fgf8, Fgf17, and Emx2
###end article-title 171
###begin article-title 172
Genomic structure, mapping, activity and expression of fibroblast growth factor 17
###end article-title 172
###begin article-title 173
Temporal and spatial gradients of Fgf8 and Fgf17 regulate proliferation and differentiation of midline cerebellar structures
###end article-title 173
###begin article-title 174
FGF17b and FGF18 have different midbrain regulatory properties from FGF8b or activated FGF receptors
###end article-title 174
###begin article-title 175
###xml 87 95 87 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xenopus </italic>
###xml 87 94 <span type="species:ncbi:8355">Xenopus</span>
Glypican 4 modulates FGF signalling and regulates dorsoventral forebrain patterning in Xenopus embryos
###end article-title 175
###begin article-title 176
###xml 51 56 <span type="species:ncbi:10090">mouse</span>
Variant heparan sulfates synthesized in developing mouse brain differentially regulate FGF signaling
###end article-title 176
###begin article-title 177
Interactions between heparan sulfate and proteins: the concept of specificity
###end article-title 177
###begin article-title 178
Heparan sulphate proteoglycans fine-tune mammalian physiology
###end article-title 178
###begin article-title 179
The loss of glypican-3 induces alterations in Wnt signaling
###end article-title 179
###begin article-title 180
Glypican-3 inhibits Hedgehog signaling during development by competing with patched for Hedgehog binding
###end article-title 180
###begin article-title 181
Neocortex patterning by the secreted signaling molecule FGF8
###end article-title 181
###begin article-title 182
BMP signaling is required locally to pattern the dorsal telencephalic midline
###end article-title 182
###begin article-title 183
Unraveling the molecular pathways that regulate early telencephalon development
###end article-title 183
###begin article-title 184
The genetics of early telencephalon patterning: some assembly required
###end article-title 184
###begin article-title 185
###xml 76 80 <span type="species:ncbi:10090">mice</span>
Neuronal production and precursor proliferation defects in the neocortex of mice with loss of function in the canonical Wnt signaling pathway
###end article-title 185
###begin article-title 186
Ongoing sonic hedgehog signaling is required for dorsal midline formation in the developing forebrain
###end article-title 186
###begin article-title 187
FGF signaling through FGFR1 is required for olfactory bulb morphogenesis
###end article-title 187
###begin article-title 188
Molecular regionalization of the neocortex is disrupted in Fgf8 hypomorphic mutants
###end article-title 188
###begin article-title 189
Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development
###end article-title 189
###begin article-title 190
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function
###end article-title 190
###begin article-title 191
The control of neuron number
###end article-title 191
###begin article-title 192
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Regulatory variation at glypican-3 underlies a major growth QTL in mice
###end article-title 192
###begin article-title 193
###xml 16 21 <span type="species:ncbi:10090">mouse</span>
Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling
###end article-title 193
###begin article-title 194
Hox control of morphogen mobility and organ development through regulation of glypican expression
###end article-title 194
###begin article-title 195
The tumor suppressor genes dachsous and fat modulate different signalling pathways by regulating dally and dally-like
###end article-title 195
###begin article-title 196
###xml 129 139 129 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 129 139 <span type="species:ncbi:7227">Drosophila</span>
The heparan sulfate proteoglycans Dally-like and Syndecan have distinct functions in axon guidance and visual-system assembly in Drosophila
###end article-title 196
###begin article-title 197
Glycobiology of the synapse
###end article-title 197
###begin article-title 198
Glycobiology of the synapse: the role of glycans in the formation, maturation, and modulation of synapses
###end article-title 198
###begin article-title 199
###xml 99 102 <span type="species:ncbi:10116">rat</span>
Cell surface heparan sulfate proteoglycan syndecan-2 induces the maturation of dendritic spines in rat hippocampal neurons
###end article-title 199
###begin article-title 200
The HSPGs Syndecan and Dallylike bind the receptor phosphatase LAR and exert distinct effects on synaptic development
###end article-title 200
###begin article-title 201
###xml 105 116 105 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 105 115 <span type="species:ncbi:7227">Drosophila</span>
Structural and functional analysis of slit and heparin binding to immunoglobulin-like domains 1 and 2 of Drosophila Robo
###end article-title 201
###begin article-title 202
Axonal heparan sulfate proteoglycans regulate the distribution and efficiency of the repellent slit during midline axon guidance
###end article-title 202
###begin article-title 203
A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype
###end article-title 203
###begin article-title 204
Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2
###end article-title 204
###begin article-title 205
Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies
###end article-title 205
###begin article-title 206
Meta-analysis of brain and cranial size in schizophrenia
###end article-title 206
###begin article-title 207
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Capturing genes encoding membrane and secreted proteins important for mouse development
###end article-title 207
###begin article-title 208
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Functional analysis of secreted and transmembrane proteins critical to mouse development
###end article-title 208
###begin article-title 209
An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination
###end article-title 209
###begin article-title 210
###xml 42 47 <span type="species:ncbi:10090">mouse</span>
Mapping Wnt/beta-catenin signaling during mouse development and in colorectal tumors
###end article-title 210
###begin article-title 211
Visualizing an olfactory sensory map
###end article-title 211
###begin article-title 212
###xml 30 38 30 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
Detection of messenger RNA by in situ hybridization to tissue sections and whole mounts
###end article-title 212
###begin article-title 213
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Expression of Sprouty genes 1, 2 and 4 during mouse organogenesis
###end article-title 213
###begin article-title 214
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
Expression of the ERK-specific MAP kinase phosphatase PYST1/MKP3 in mouse embryos during morphogenesis and early organogenesis
###end article-title 214
###begin article-title 215
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Conservation of the hedgehog/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog
###end article-title 215
###begin article-title 216
Image J
###end article-title 216
###begin article-title 217
Central roles of the roof plate in telencephalic development and holoprosencephaly
###end article-title 217
###begin article-title 218
Direct and indirect roles of central nervous system dorsal midline cells in choroid plexus epithelia formation
###end article-title 218
###begin article-title 219
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
###end article-title 219
###begin article-title 220
The bicinchoninic acid (BCA) assay for protein quantitation
###end article-title 220
###begin article-title 221
###xml 77 80 <span type="species:ncbi:10116">rat</span>
A diverse set of developmentally regulated proteoglycans is expressed in the rat central nervous system
###end article-title 221

